In September, the FDA began posting on its web site a list of drugs it is investigating for adverse side effects. The new program is required by Congress, in response to public demand for more transparency in the drug investigation process. Here, Legal Briefs' Amy Yeargan talks about the program.

Recorded: Monday, September 15, 2008

Courtesy of: Beasley Allen Video

Keywords: Pharmaceutical, General Pharmaceutical